AMSTERDAM: Dutch health technology company Philips has set aside 575mil (US$631mil or RM2.8bil) for possible litigation costs related to its global recall of respiratory machines.
Amsterdam-based Philips is grappling with the fallout of a global recall of millions of respirators used to treat sleep apnoea, announced in June 2021 over worries that foam used in the machines could become toxic.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
